1st indigenous KF-21 fighter jet enters final assembly phase
The first production model of South Korea's homegrown KF-21 fighter jet entered final assembly Tuesday, the state arms procurement agency said, in a major milestone for the advanced aircraft acquisition project.
A ceremony marking the final production phase took place at Korea Aerospace Industries Ltd.'s headquarters in Sacheon, about 290 kilometers southeast of Seoul, according to the Defense Acquisition Program Administration.
During the phase, the aircraft will be fully assembled with external and internal components and undergo various performance tests before proceeding to flight testing, according to DAPA.
South Korea launched the KF-21 development program in 2015 to acquire a homegrown supersonic fighter to replace the Air Force's aging fleet of U.S.-made jets, including the F-5.
Mass production of the so-called 4.5-generation fighter jet began last July after years of development and prototype testing, and the first model is scheduled to be delivered to the Air Force in the second half of next year.
DAPA said the aircraft is on track with the project's schedule, expressing expectations the latest development will have a positive impact on the potential exports of the aircraft.
In June last year, KAI signed a 1.96 trillion-won ($1.41 billion) deal with DAPA to build 20 KF-21s through 2027. The country seeks to operate 120 KF-21s by 2032. (Yonhap)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
6 days ago
- Korea Herald
Korea University opens doors to Harvard international students blocked by Trump's crackdown
Korea University has announced plans to welcome professors, researchers and students from Harvard University following a move by the Trump administration to revoke the enrollment of international students at Harvard. The university is the first in South Korea to formally step forward with an offer of support for those affected. Korea University, one of the country's most prestigious educational institutions, said it would launch a special program to assist Harvard-affiliated international professors, postdoctoral researchers, graduate students and undergraduates who are facing uncertainty due to the US government's restriction on foreign student enrollment. Under the initiative, undergraduate and graduate students will be able to continue their studies at Korea University through transfer admissions or exchange programs. The university also pledged to ensure that credits earned could be transferred when students return to Harvard. The university seeks to appoint distinguished international faculty, including scholars from Harvard, as visiting professors with support such as housing and relocation assistance. 'In times like these, we must ensure that the next generation of scholars can continue their academic journeys without disruption,' said Kim Dong-won, president of Korea University. 'We will do all we can to support talented individuals whose education and research have been jeopardized.' The Trump administration formally notified Harvard University that its Student and Exchange Visitor Program certification had been revoked on May 22, barring the university from hosting international students on F-1 or J-1 visas. However, a US court issued a temporary injunction the next day, allowing affected students and researchers to retain their visa status while legal proceedings are underway.
Korea Herald
26-05-2025
- Korea Herald
From mussels to hair: How a KAIST scientist turned polyphenol into a global shampoo hit
Selling out in Paris and with CES buzz, Grabity shampoo gains traction on global stage It all started with mussels. How do they cling so tightly to rocks underwater without hands? The answer lies in polyphenol — a transparent, adhesive substance they secrete. Inspired by this natural phenomenon, Lee Hae-sin, a leading chemical engineering professor at the Korea Advanced Institute of Science and Technology, developed Grabity shampoo — a runaway hit that grips hair the way mussels cling to rocks. Since its launch in April last year, over 1.2 million units have been sold, with sales of 20 billion won ($14.6 million). The shampoo has demonstrated a remarkable ability to reduce hair loss by up to 70 percent — and by as much as 90 percent among patients clinically diagnosed with hair loss — making it a breakout success for Lee's startup, Polyphenol Factory. Born in a science lab, the shampoo is now setting its sights on global expansion, with its proven effectiveness aimed at tapping into the billion-dollar hair loss treatment industry. 'We're just a little over a year old as a brand, and the popularity we gained in Korea gave us the confidence to go abroad,' Lee said in an interview with The Korea Herald on May 16, the day he returned to Seoul from Paris, where his company showcased Grabity at Foire de Paris 2025, one of Europe's largest consumer trade fairs. 'But we didn't expect to receive such an overwhelming response from people of different nationalities and ethnicities, since the product was originally developed with Korean consumers in mind.' From lab to locks: The science behind a viral hair loss fix At Foire de Paris 2025, Polyphenol Factory's booth drew about 10,000 visitors on the first day alone, with all 5,000 units of Grabity shampoo selling out. An additional 5,000 units brought in by the company quickly sold out as well. 'I had never tested or sold our product to what you'd call a Western demographic, but I found that people were genuinely interested,' Lee said, noting that one visitor even returned the next day with a friend after trying the product. 'Despite differences in hair types, Grabity proved to be effective.' Grabity received similarly enthusiastic responses during its US debut at CES 2025, the world's largest annual tech and consumer trade show held in January in Las Vegas. Grabity shampoo and treatment products are currently available on Amazon, but Lee is preparing for an official launch in the US and other major markets. Polyphenol Factory has partnered with Lotte Home Shopping to expand into several European countries as well as Japan and Taiwan. The key ingredient that helps Grabity hold hair in place is polyphenol, a natural compound commonly found in plants. 'The adhesive has to withstand exposure to water during shampooing, and polyphenol is a great substance that has this capability,' Lee explained. While shedding 50 to 70 hairs per day is normal for a healthy scalp, individuals experiencing hair loss may shed over 100 strands daily. As hair strands become thinner and narrower than the pores they grow from, they loosen and more easily fall out. Grabity's formula addresses this by filling that gap — the polyphenols form bonds between the hair strand and the pore wall, acting as a natural adhesive to hold hair in place. 'In our clinical study with patients diagnosed with hair loss, daily hair shedding dropped by up to 90 percent, with some seeing results in just two weeks,' Lee said. 'Someone losing 100 strands a day saw that fall to around 30.' In 2023, Lee registered his lab as a faculty-led startup at KAIST, where the ingredients were specially processed into a high-adhesion form. The resulting technology was patented under the name LiftMax 380. This processed polyphenol sets Grabity apart from many other shampoo products on the market that claim to use the compound. According to Lee, most products simply add polyphenol extracts into a conventional shampoo base. 'It's more like turning soybeans into tofu,' he explained. 'You're not just adding a raw ingredient — you're changing its form and function.' For Grabity, Lee's lab uses extracts from walnut shells. How blood vessel breakthrough became hair care hit Lee's work with polyphenol dates back to his postdoctoral research at the Massachusetts Institute of Technology, where he studied how the compound could be used to deliver anti-inflammatory drugs directly to the walls of blood vessels — helping prevent arterial narrowing, a key factor in conditions like arteriosclerosis and cerebral infarction. 'To prevent blood vessels from narrowing and becoming blocked, the anti-inflammatory drug needs to be delivered precisely to the affected vessel. But it was always challenging because blood flows at an incredibly fast speed — faster than cars on a highway,' Lee said. 'Polyphenols have made this targeted delivery possible.' He published his research and transferred the technology to a Japanese company. Learning that polyphenols bond well to blood due to its high plasma protein content, Lee was inspired to develop his next invention: a hemostatic agent. 'When I thought about what might work outside the body, hair came to mind easily, because it's made of keratin — a protein,' he said. Grabity's production remains limited, as the LiftMax 380 solution is mixed in-house by a 15-member team, including seven core researchers, before being manufactured by a partner factory. With demand surging — and resale prices on secondhand platforms reaching up to seven times the original price when the product sells out — Polyphenol Factory is planning to expand its production capacity. Still, Lee is clear that scaling up the company is not his ultimate goal. 'We often talk about 'innovation in the everyday,'' Lee said. 'Polyphenols can be used in highly technical applications, but I wanted to create products that people can actually feel and use in their daily lives — something accessible, not just advanced.' New products using the same nature-driven material are already in the pipeline, including nail and eyelash adhesives, and even a solution for hair implantation. His research has shown that polyphenol-based adhesives can effectively implant hair without follicles. While the implanted hair does not grow, it can visibly fill in thinning areas — a solution Lee believes could be especially helpful for women experiencing small, patchy hair loss. 'We're not a cosmetics company. We're a tech company,' he said, emphasizing his role as a researcher. Lee, now an endowed chair in KAIST's department of chemistry, in his career has authored 237 papers and holds 68 technology patents. 'If there's no clear scientific foundation behind what we offer, we won't expand product lines just for the sake of it. We don't do concept-only products. That's our guiding principle.'
Korea Herald
22-05-2025
- Korea Herald
KAI CEO calls for swift resolution with Indonesia on KF-21 issues
By Hwang Joo-young and Joint Press Corps LANGKAWI, Malaysia — Korea Aerospace Industries CEO Kang Goo-young on Wednesday expressed hopes for a swift resolution to tensions with Indonesia, which joined the company as a key partner in 2016 in the development of the KF-21 fighter jet — KAI's most advanced 4.5-generation aircraft project. The partnership has soured since 2023, when several Indonesian technical researchers were caught attempting to remove sensitive files from the joint development site in Korea using an unauthorized USB device. Five of the personnel are under investigation and remain banned from leaving the country, which is believed to be a source of growing dissatisfaction in Jakarta. Speaking with South Korean reporters at the LIMA 2025 defense exhibition in Langkawi, Kang said the issue should be 'resolved amicably within the legal framework,' expressing concerns that prolonged friction with Indonesia could complicate broader efforts to promote the KF-21 across the region. Despite speculation that Indonesia may be preparing to withdraw from the KF-21 program, Kang said he does not believe that to be the case. Indonesia still owes about 200 billion won ($145.8 million) in development costs — 100 billion won for this year and another 100 billion for next year — and according to Kang, the Indonesian government has already budgeted the 2024 payment. "That's not a signal of withdrawal," he said, adding that Indonesia is closely monitoring the KF-21's progress and is unlikely to walk away easily. Still, Kang acknowledged that deteriorating ties with Jakarta could shift the regional dynamic. He pointed to Indonesia's growing interest in co-developing Turkey's next-generation fighter, the KAAN, and said that if Malaysia were to join such an initiative, it could complicate South Korea's broader ambitions in Southeast Asia. Restoring cooperation with Indonesia, he stressed, is not just about preserving bilateral ties — it's also about maintaining strategic footing in a competitive market. Kang noted that many Southeast Asian countries view China as a growing security concern. 'In the past, China used battleships to project power,' he said. 'Now it's aircraft carriers.' This shift, he added, is prompting countries such as Indonesia, the Philippines and Malaysia to seek high-performance fighter jets. Although many would prefer the F-35, US export restrictions make that difficult, giving the KF-21 an opening. Interest in the aircraft is also growing. According to Kang, a high-ranking Malaysian official visited the KAI booth during the exhibition and asked how the KF-21 compares with China's J-10 fighter. On May 7, a Pakistani J-10 reportedly shot down a Rafale fighter from the Indian Air Force, which had acquired the jets from France. In that conversation, Kang said he positioned the KF-21 as a cost-effective but high-performance alternative to European fighters. 'Compared to 4.5-generation jets like the Rafale or Eurofighter, the KF-21 delivers 150 percent of the performance at 70 to 80 percent of the cost,' he told the official. In an effort to keep the partnership with Indonesia on track, South Korea has offered to reduce the country's share of development costs from 1.6 trillion won to 600 billion won. However, Jakarta has not officially responded. KAI has also submitted multiple petitions to the South Korean authorities requesting leniency for the Indonesian personnel involved in the data breach, arguing that the leaked materials likely did not contain core technical information. 'We hope this can be resolved through political and diplomatic channels,' Kang said. 'From a national interest standpoint, it's time to move beyond this dispute.'
